Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts
- 22 November 1999
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 18 (49) , 6888-6895
- https://doi.org/10.1038/sj.onc.1203236
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 60 references indexed in Scilit:
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- RelB Is Essential for the Development of Myeloid-Related CD8α− Dendritic Cells but Not of Lymphoid-Related CD8α+ Dendritic CellsImmunity, 1998
- Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune ResponsesThe Journal of Experimental Medicine, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- IκBα Overexpression Delays Tumor Formation in v-rel Transgenic MiceThe Journal of Experimental Medicine, 1997
- p50–NF-κB Complexes Partially Compensate for the Absence of RelB: Severely Increased Pathology in p50−/−relB−/−Double-knockout MiceThe Journal of Experimental Medicine, 1997
- Immunological defects in mice with a targeted disruption in Bcl-3.Genes & Development, 1997
- The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimersCell, 1993